Oncogenic histone methyltransferase EZH2: A novel prognostic marker with therapeutic potential in endometrial cancer

Shinya Oki(Kumamoto University), Tomoyuki Fujii(Tohoku University)
Oncotarget
March 17, 2017
Cited by 67


Related Papers